Disease / condition
Solid Tumors clinical trials
Free access to 417 studies10+ countriesUpdated daily68 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
417
Total trials
10+
Countries
10+
Sponsors
68
Recruiting
By phase
Phase 1302
N/A40
Early Phase 132
Phase 228
Phase 1/29
By status
Completed236
Recruiting68
Terminated37
Not yet recruit...31
Unknown20
Top countries
United States of America157
China45
Japan22
Italy8
Singapore6
Top sponsors
Hoffmann-La Roche21
AstraZeneca12
M.D. Anderson Canc...12
Novartis Pharmaceu...11
Incyte Corporation11
Recent trials
Latest clinical trials for Solid Tumors
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co... · Australia
NCT06418061Not yet recr...
- Phase
- Phase 1
Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
Sound Biopharmaceuticals Ltd. · China
NCT06410131Not yet recr...
- Phase
- Phase 1
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
Jacobio Pharmaceuticals Co., L...
NCT06386146Not yet recr...
- Phase
- Phase 1/2
A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)
Hoffmann-La Roche · Spain
NCT06331598Recruiting
- Phase
- Phase 2
Spatial Profile of Tumors
Fondazione Policlinico Univers... · Italy
NCT06298773Not yet recr...
A Study of IBI363 in Subjects With Advanced Solid Malignancies
Innovent Biologics (Suzhou) Co... · United States of America
NCT06281678Not yet recr...
- Phase
- Phase 2
A Study of ZG005 in Patients With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceutica... · China
NCT06233292Recruiting
- Phase
- Phase 1/2
QTX3034 in Patients With KRAS G12D Mutation
Quanta Therapeutics · United States of America
NCT06227377Recruiting
- Phase
- Phase 1
A Study of Adverse Events, How Intravenously (IV) Infused ABBV-303 Moves Through the Body, and Change in Disease State, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adult Participants With Advanced Solid Tumors
AbbVie
NCT06158958Not yet recr...
- Phase
- Phase 1
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
Gilead Sciences · Australia,United States of America
NCT06082960Recruiting
- Phase
- Phase 1
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
M.D. Anderson Cancer Center · United States of America
NCT06066424Recruiting
- Phase
- Phase 1
A Study of ADRX-0706 in Select Advanced Solid Tumors
Adcentrx Therapeutics · United States of America
NCT06036121Recruiting
- Phase
- Phase 1
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
Imbioray (Hangzhou) Biomedicin...
NCT06001684Not yet recr...
- Phase
- Phase 1
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors
Takeda · Hungary
NCT05976334Not yet recr...
- Phase
- Phase 1
A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors
Xencor, Inc. · United States of America
NCT05996445Recruiting
- Phase
- Phase 1
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
SYZ Cell Therapy Co.. · China
NCT05877651Completed
- Phase
- Phase 1
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
Boehringer Ingelheim · United States of America
NCT05839600Recruiting
- Phase
- Phase 1
Study of ARTS-021 in Patients With Advanced Solid Tumors
Allorion Therapeutics Inc
NCT05867251Not yet recr...
- Phase
- Phase 1/2
IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co... · Australia
NCT05774873Not yet recr...
- Phase
- Phase 1
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
Shandong New Time Pharmaceutic... · China
NCT05740215Recruiting
- Phase
- Phase 1/2
About this profile
Access comprehensive clinical trial information for Solid Tumors through Pure Global AI's free database. This collection includes 417 clinical trials across multiple phases including Phase 1, N/A, Early Phase 1. Currently, 68 trials are actively recruiting participants.
Research for Solid Tumors is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Hoffmann-La Roche and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 417 clinical trials studying Solid Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Hoffmann-La Roche, AstraZeneca, M.D. Anderson Cancer Center, among others.